Category Archives: Stem Cell Doctors


The International Space Station creates bigger, colder states of matter than are possible on Earth – Massive Science

Eight years ago, I was packing my home and entire life in Mexico to move to the US to pursue a PhD in Ecology and Evolutionary Biology at the University of California-Irvine. Those were easier times, although it did not seem like it at the time. I spent a few months worth of income to pay for paperwork to apply for an F-1 student visa, and to pay for other documents to enroll as a graduate student. This was after I dedicated months to emailing professors everywhere in the US, hoping that one of them would reply to my email and would invite me to apply to join their lab. It was also after spending time and money paying for standardized tests, official document translations, and application fees. It was a one-and-a-half-year process but in July 2012, I was finally moving to the USA to pursue my PhD. It was a dream come true.

It was also a dream come true for the University of California because I had a full scholarship from my home country that paid for the entirety of my international tuition and fees, which were around $35,000 per year. My scholarship allowed me to pursue my PhD in the USA, and to UC Irvine it provided basically free labor as well as prestige.

I paid taxes and did all of the typical graduate student responsibilities. I also dedicated a lot of my time to doing outreach to bring science to underserved communities around Orange County and Southern California. By the time I graduated in 2017, I was a stellar student, with three publications with UC Irvine's name on them. I co-organized summer science camps for middle school girls that brought money and a good reputation to my university and program. I mentored students of all ages. I was a good citizen of my program, of my university, and of Orange County.

Like me, most international students leave their families and everything that they are comfortable with to pursue the dream of graduate school. They bring with them the hope of being welcomed and treated fairly by their American peers. I have experienced this, but I am one of the lucky ones.

It is no secret that international students and postdocs will withstand abuse and other injustices just so they can keep their visa, which is always tied to their university. Many universities receive international students without having a system to deal with the unique challenges that international students face, such as having no credit history, which complicates finding a place to live and leaves international students vulnerable to landlord abuse. Many international students are people of color, and universities, especially predominantly white institutions, do not have resources to ensure safety of these students within the university and in the community at large.

These challenges are further complicated due to a lack of community and support. Making friends in the US, especially if you are coming from Global South countries and/or non-Westernized countries, is extremely challenging. Many times, I have seen how western Europeans, Australians, and Canadians are rapidly accepted in the local community, while many Latinx, Asians, and Middle-Easterners are not.

There are over one million international students in the US. The ICE Student Ban may no longer be a threat, but universities still need to change how they handle international students. We are people too, but many universities have historically valued us only by the amount of money we bring. We improve higher education not only by the money that we bring, but by our unique perspectives, our research productivity, and our willingness to give back to American society.

See the original post:
The International Space Station creates bigger, colder states of matter than are possible on Earth - Massive Science

Out-of-Pocket Costs Often Higher Than Expected for Patients with Cancer Participating on Clinical Trials – Curetoday.com

According to the lead study investigator, work needs to be done to ensure financial toxicity is not a deterrent to clinical trial enrollment and that trial sponsors and payers should consider trial expense reimbursement.

Clinical trials have additional visits and costs compared to the standard of care, Dr. Ryan W. Huey, an assistant professor in the department of gastrointestinal medical oncology at The University of Texas MD Anderson Cancer Center in Houston, said during a pre-recorded presentation of the data. And while financial toxicity has been well described for patients with cancer, it is less well established for patients who enroll in clinical trials.

To evaluate financial toxicity, which is the direct and indirect impact of health care costs that lead to significant financial burden, and out of-of-pocket costs for patients with cancer enrolled in early phase clinical trials, Huey and colleagues surveyed patients who were on a trial for more than a month. The goal, Huey said during the presentation, was to talk to patients who accurately understood what their monthly expenses were while on their respective trial.

The researchers collected data regarding patient demographics, including, but not limited to, patient and disease characteristics, as well as insurance status.

Using the 12-question COmprehensive Score for Financial Toxicity (COST)Functional Assessment of Chronic Illness Therapy (FACIT) survey, the researchers assessed the financial toxicity that 213 patients (with a median age of 59 years) in early-phase clinical trials experienced. More than half of the trial participants surveyed were female (59%) and more than three-fourths (79%) were non-Hispanic white. Other characteristics patients were grouped by included yearly household income, type of insurance, employment status and length of time spent on current trial.

More than half of the participants (55%) had employer-provided insurance, 38% had Medicare, 11% had personally purchased insurance and the remaining participants had either Medicaid (2%), VA-provided insurance (4%), personally purchased supplemental insurance (9%) or other (1%).

Forty percent of the patients were employed either full- or part-time, while 37% were retired and 15% were unemployed.

Half of the participants traveled more than 300 miles to receive their cancer care. The other half either traveled less than 100 miles (23%) for their cancer care or traveled 101 to 300 miles (27%).

Thirty percent of the participants were either fully (6%) or partially (24%) reimbursed for their travel.

Out-of-pocket, patients spent a median of $1,075 a month on non-medical expenses. Expenses attributed to medical costs accounted for $475 out-of-pocket per month. The survey demonstrated that more than half (55%) of patients felt that their expenses attributed to medical costs were higher than expected. Sixty-four percent of patients also reported that they felt their non-medical expenses were higher than expected.

Factors associated with a worse financial burden included an annual household income of less than $60,000, participating on at least one previous phase 1 clinical trial and living more than 100 miles away from the clinical trial site.

Huey concluded his presentation noting that the economic burden patients participating on clinical trials experience is high, and that most of the costs are related to nonmedical expenses.

Financial toxicity disproportionately affects patients with lower income and those who travel far to receive their care, he said. And costs are often higher than expected. Work needs to be done to ensure this financial toxicity is not a deterrent to enrollment. And sponsors and payers should consider the role of trial expense reimbursement.

Visit link:
Out-of-Pocket Costs Often Higher Than Expected for Patients with Cancer Participating on Clinical Trials - Curetoday.com

Biotechnology Reagents Market To Witness Massive Growth Worldwide | Global Players Abbott, Agilent Technologies Inc., Danaher, Bd, Bio-Rad…

Wide ranging Biotechnology Reagents Market report provides better ideas and solutions in terms of product trends, marketing strategy, future products, new geographical markets, future events, sales strategies, customer actions or behaviours. Statistical data mentioned in this market document is symbolized with the help of graphs which simplifies the understanding of facts and figures. With the precise and high-tech information, about Healthcare industry, businesses can know about the types of consumers, consumers demands and preferences, their perspectives about the product, their buying intentions, their response to particular product, and their varying tastes about the specific product already existing in the market through this Biotechnology Reagents Market report.

Biotechnology Reagents Market analysis report helps in growing sales with new thinking, new skills, and innovative programs and tools. With the study of competitor analysis, Healthcare industry can get knowhow of the strategies of key players in the market that includes but are not limited to new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions. An all-inclusive data and information provided in the report can be utilized by Healthcare industry to be acquainted with the present and upcoming opportunities and clarify the future investment in the market. The Biotechnology Reagents Market report will act as a sure shot solution to the challenges and problems faced by Healthcare industry.

Get Sample PDF (including COVID19 Impact Analysis) of Market Report @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-biotechnology-reagents-market&rp

Market Analysis: Global Biotechnology Reagents Market

Global biotechnology reagents market is expected to rise from its initial estimated value of USD 65.82 billion in 2018 to an estimated value of USD 118.53 billion by 2026, registering a CAGR of 7.63% in the forecast period of 2019-2026. This rise in market value can be attributed to the significant investments by private players in biotechnology.

Key Market Competitors:

Few of the major competitors currently working in thebiotechnology reagents marketareAbbott, Agilent Technologies Inc., Danaher, BD, Bio-Rad Laboratories Inc., General Electric, bioMrieux SA, LONZA, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hoefer, Inc., Meridian Bioscience, Inc., PerkinElmer Inc., Merck KGaA, Promega Corporation, Quality Biological, Siemens AG, Bio-Techne, TAKARA HOLDINGS INC., Sysmex Corporation, Tosoh Corporation, WATERS, W. R. Grace & Co.-Conn., Ortho Clinical Diagnostics, Olympus Corporation and Fitzgerald Industries International among others.

Get Full TOC, Tables and Figures of Market Report @https://www.databridgemarketresearch.com/toc/?dbmr=global-biotechnology-reagents-market&rp

Market Definition: Global Biotechnology Reagents Market

Biotechnology reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, genetics, molecular biology, diagnosis, immunology and bioscience. Biotechnology reagents comprises of technologies such as cell culture, spectrometry, IVD, PCR, chromatography, expression and transfection, flow cytometry, and electrophoresis, and find their application in areas such as immune phenotyping, fluorescent microscopy, DNA analysis and cell cycle analysis.

According to the Innovative Research, in U.S., around 65% of biotech companies are involved in drug developed with an intention to serve them for medical purposes and pharmaceuticals. Growing number of biotechnology firms in various countries is expected to act as a driver for the market growth.

Biotechnology Reagents Market Drivers :

Biotechnology Reagents Market Restraints :

Segmentation: Global Biotechnology Reagents Market

Biotechnology Reagents Market : By Technology

Biotechnology Reagents Market : By Applications

Biotechnology Reagents Market : By Geography

Key Developments in the Biotechnology Reagents Market :

Competitive Analysis:

Global biotechnology reagents market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of biotechnology reagents market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Research Methodology: Global Biotechnology Reagents Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more pleaseRequest an Analyst Callor can drop down your inquiry.

The key research methodology used byDBMR Researchteam is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents :

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report :

Customization of the Report :

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biotechnology-reagents-market&rp

About Data Bridge Market Research :

Data Bridge Market Researchis a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us :

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Mail:[emailprotected]

Read the rest here:
Biotechnology Reagents Market To Witness Massive Growth Worldwide | Global Players Abbott, Agilent Technologies Inc., Danaher, Bd, Bio-Rad...

Fear, Courage, Grit: Meet More Than 50 ‘Hospital Heroes’ – WTOP

They Arent Backing Down The pandemic has dealt a massive blow to the country and world. Front-line health care workers

They Arent Backing Down

The pandemic has dealt a massive blow to the country and world. Front-line health care workers from coast to coast have gone above and beyond the call of duty pushing further in the face of fear than anyone can imagine. Many dont consider themselves heroes some even bristle at the word but U.S. News is chronicling their experiences, along with their hopes, fears and the lessons theyre learning during this historic year. In the slides ahead youll meet a nurse who came out of retirement to work alongside her daughter, a physician treating patients in the hard-hit Navajo Nation and so many more. These are U.S. News Hospital Heroes.

Dr. Rana Awdish

A critical care doctor on the front lines at Henry Ford Health System in Detroit, Awdish prepared herself, her family and her team for the inevitable hit from the virus. And it hit hard. Drawing on her experience as a patient on a ventilator after her own life-threatening medical emergency in 2008, she found herself in a unique position to understand the fear, pain and loneliness that her patients with COVID-19 were feeling at a personal level. Read her entire story.

Anticipating that kind of trauma will never protect you from it.

Father Chris Ponnet

Father Ponnets work as director of spiritual care at LAC+USC Medical Center brings end-of-life peace to patients and to their families, especially during the coronavirus pandemic, when loved ones are unable to be present at the end. He does his best to make patients feel seen while cataloging as much as he can of his time to share with the patients family. He wears an N95 mask, goggles, a face shield and a disposable gown and gloves to minister to these patients. Read his entire story.

My role is to be a bridge between the family and the patient, Ponnet says. I want to capture as much of what is happening in the room as possible, to report to the family.

Esbeda Refugio

Making the choice to continue her work as a custodian at LAC+USC Medical Center in the midst of the novel coronavirus pandemic was not an easy one for Refugio. As a single mom of four children, she worried about bringing the virus home. However, her sense of duty to both the patients and the other hospital employees ultimately made the decision for her. Donning PPE, Refugio cleans two to three COVID rooms a shift, though she treats all rooms as if the patients were COVID-positive given the infectious nature of the disease. Read her entire story.

Its my responsibility to protect others, not only when it comes to patient care, but also the doctors, the nurses and the respiratory techs who go into the room, she says. I want everybody to be safe, so I clean to the best of my ability.

Patrick OConnor

OConnor isnt a doctor or nurse, but his role is no less essential. When the pandemic first landed at LAC+USC Medical Center, OConnor, supervisor of the carpentry shop at the hospital, worked with his team to make adjustments to intubation boxes placed over patients who need a tube inserted to help them breathe. The original boxes didnt provide enough coverage for doctors and nurses exposed to a patients infectious respiratory droplets as they performed the procedure. His team also built rooms for donning and doffing PPE in a safe environment. Read his entire story.

Were in the background, doing things to make things safer for the doctors, nurses and other health care workers and staffers, he says. Thats why were here.

Dr. Josh Mugele

As New York City became the coronavirus epicenter, Mugele, an emergency medicine physician in Georgia, felt it was his duty to help in any way he could. This, for him, meant boarding a plane and heading straight into the line of fire, volunteering at one of the citys hard-hit public hospitals. While there, he treated many patients, including one of the hospitals own nurses whod fallen ill with COVID-19. One of his goals was to learn as much as he could about how best to treat COVID-19, so he could bring those lessons back to his hometown hospital. By the time he returned to Georgia, cases were climbing sharply. Read his story.

This is going to take a long time, he says. Were going to have to change the way we live, the way we practice medicine and the way we make policies for years to come.

Jody Mugele

Before Mugeles husband, Dr. Josh Mugele, left to volunteer on the COVID-19 front lines in New York, the couple went through what they call the death document. A ritual they started before Dr. Mugeles disaster medicine fellowship in Liberia in 2013 during the Ebola outbreak, the document contains anything she may need in the case of his death, along with letters he wrote to her and their two kids. He was gone for nearly a month before safely returning. Read her story.

It really was the loneliest I think Ive ever felt, says Jody. I was talking to the dogs like theyre my best friends.

Jeanette Trella

Back in February, when calls started trickling into the Poison Control Call Center Trella manages at the Childrens Hospital of Philadelphia, she knew it was just the beginning. Her team is usually the first to hear about medical emergencies before they grow bigger. Sensing then that COVID-19 would pick up steam, she raced to launch the Greater Philadelphia Coronavirus Help Line, which has helped advise callers on everything from symptoms to economic woes tied to the pandemic. Read her entire story.

We often get calls about dangerous trends right when theyre starting.

Dr. Steven Brown

For 20 nights a month, Brown monitors as many as 100 patients a night virtually from a command station now in his living room. A pulmonologist for Mercy Virtual Care Center, he helps on-the-ground clinicians like nurses and respiratory therapists care for patients with COVID-19, often in rural areas that need support and guidance. Through his screens he has made tough decisions and seen many people die once, three in one hour. However, he is hopeful that once researchers discover more about the virus weak spots, a vaccine will be created. Read his story.

If we listen to scientists, accept facts and make educated decisions based on the best available data, we will be able to drive down the number of cases of COVID-19.

Mary Beth Patterson

Patterson thought shed left her days as a nurse behind her when she retired over a year ago to move to New Hampshire. But when Stony Brook University Medical Center, her old stomping grounds and the same hospital where her daughter works as a nurse, started seeing an influx in COVID-positive patients, she made the decision to come out of retirement to help. Read her story.

I just felt compelled to come back to work and be alongside my daughter during this pandemic.

Kelly Patterson

When her mom made the decision to come out of retirement and return to nursing during the pandemic, Kelly Patterson was initially nervous. A young nurse at Stony Brook Medical Center, just a few years out of school, Patterson worried that her moms age would be a risk factor. During the height of the crisis, she was glad to have her moms knowledge of patient care and empathy skills more important now than ever. Though they work opposite shifts Kelly at night and her mom during the day she stops by to see her at the beginning and end of each shift. Read Kellys entire story.

Youre seeing death almost every shift, Kelly says. Its not a soothing, comfortable death. Theyre not accompanied by their loved ones, not able to see them or talk to them. Its very sad.

Felix Khusid

A veteran respiratory therapist at New York Presbyterian Brooklyn Methodist, Khusid sees patients at the terrifying height of the disease, when they feel like their lungs are filled with water. His job then becomes to do whatever he can to help them stay alive, ideally without a ventilator. This sometimes includes high-flow therapy, which pushes concentrated levels of oxygen into the body and helps patients breathe on their own for longer. Read his entire story.

During this epidemic, what was really emphasized I think for the whole world is the expert job that the respiratory therapists are doing, he says. Its a profound responsibility that has profound consequences.

Dr. Gregg Rosner

Rosners experience as a cardiac intensivist at New York Presbyterian/Columbia University Medical Center didnt necessarily prepare him to treat patients with a disease that primarily attacks the lungs. However, when the pandemic struck his hospital, he stepped up to lead the COVID-19 intensive care unit. In the beginning, the ICU team faced many unknowns, including how best to wear PPE to protect themselves. Rosner set the tone for his new team. I couldnt be scared. I couldnt be unsure, he says. We had a team with an impossible task and I was amazed at how everyone in the hospital stepped up. Read his story.

The coronavirus affected everyone of all races and all ages; people who were sick before and people who werent sick before, Rosner says.

Erica Harris

Erica Harris has been a nurse at NYC Health + Hospitals Elmhurst in Queens for 20 years, and shes never seen anything like the novel coronavirus before. Harris leads the hospitals COVID-19 testing tent which, at opening hour, rarely sees lines of fewer than 15 to 20 people, mostly the working-class immigrants her hospital serves. The outdoor tent met the overwhelming need for increased testing and took teamwork to create the negative pressure rooms inside it that keep virus particles from flowing everywhere. Read her entire story.

Once you faced the challenge and the last two months have been a challenge you feel stronger on the other side.

Dr. Vonzella Bryant

One of Bryants first COVID-positive patients at Boston Medical Center came in with an oxygen level of 75% far outside the normal range of 95% to 100%. In an effort to prevent intubation, Bryant, an emergency medicine physician, turned him over onto his stomach, a technique called proning. Luckily, the patients levels went back up to normal. Bryant and her family may have seen one of the earlier cases of the virus at home when her mother, who lives with the family, returned from vacation with telltale symptoms. After recovering and quarantining for 14 days, her mother now takes care of Bryants two kids, as Bryant juggles work on the front lines. Read her full story.

At the hospital, we were being hit all at once with sick, agitated and sometimes combative patients; scared and nervous essential workers; staff with underlying conditions who were afraid of getting the virus; and we were fearful that wed run out of ICU space.

Dr. Yinan Lan

When coronavirus patients started flooding into NYC Health + Hospitals Bellevue, Lan, a primary care physician, knew from her already extensive work with the homeless population in the city that things would be even worse for those who lived in shelters or on the streets. Her team set up a system to keep track of patients and ensure they have a place to stay, enough food and medication, and are as healthy as possible especially during this time of uncertainty. Read her story.

When theres a will to do that, it takes everyone not just a city agency, not just a few nonprofit organizations or hospitals.

Bre Loughlin

One-half of the nursing duo that developed virtual coronavirus screening for the single womens shelter at the Salvation Army Dane County in Madison, Wisconsin, Loughlin came up with the idea when she visited a mens shelter and talked to workers. They described the challenges in screening guests for the virus, including the gap in knowledge of lay volunteers who werent equipped to properly screen for the disease. With the help of donated tablets, a Wi-Fi hotspot and volunteer nurses, the first virtual screening at the shelter began. Read Loughlins entire story.

We had to think about at what point we would bring people into the trailer, maintain distancing, where we would place the PPE. All of that was part of the design of the screening we were able to pop up in 48 hours.

Tracy Zvenyach

The other half of the nursing duo that developed virtual screening for homeless shelters in Madison, Wisconsin, Zvenyach has seen a lot of grateful people come through the testing centers, especially since the team makes it a priority to guarantee housing for the night no matter the outcome of the test. Read her entire story.

One of the most daunting things about the pandemic is that, while we have our essential front-line workers, theres this enormous secondary front line in the community.

Dr. Dominic Carollo

Carollo, an anesthesiologist at Ochsner Medical Center in Louisiana, knows firsthand what his COVID-19 patients endure. Almost a week after he started working in the COVID intensive care ward, he developed a dry cough. Hed caught the virus. When his symptoms started to get scary, he relied on his medical training and buckled up for a one-on-one battle with COVID-19. I put an IV in and I gave myself 2 liters of fluid, he says. Almost two weeks later, his symptoms were gone and he went right back to treating patients. Read Carollos full story.

Every COVID shift that I could work is one less exposure for one of my colleagues.

Dr. Kyle Annen

In March, Annen, the medical director of transfusion services and patient blood management at Childrens Hospital Colorado, received a call about a critically ill adult patient with COVID-19, whose family urgently wanted their loved one to get a transfusion of convalescent plasma. They had heard that plasma from people who had recovered from COVID-19 may help. Other centers werent equipped to snap into action, so Annens team raced to launch a massive effort. In only a few weeks, they collected enough plasma donations for more than 150 patients. Read Annens entire story.

I think people who had COVID want to help, Annen says. They feel its a way they can make a direct impact to help someone who had it worse than they did.

Jessica Hawks

When the pandemic hit the U.S., the Pediatric Mental Health Institute at Childrens Hospital Colorado stopped offering in-person visits to prevent the spread of COVID-19. So Hawks, the clinical director of outpatient services, and her team pivoted to provide behavioral health care via telehealth to ensure kids with everything from eating disorders to depression didnt experience a lapse in care. Though there were privacy concerns and technology barriers to contend with, Hawks and her teammates got the program up and running. Read her story.

It was very clear that (telehealth services) was something wed need to offer to our patients and their families during this stressful time.

Pat Givens

As PPE shortages plague hospitals, Pat Givens, the chief nursing executive at Childrens Hospital Colorado, and her colleagues developed a system to track gear such as N95 masks and gowns. Their work ensured that even amidst a global shortage, the hospital would not run out of protective necessities. Read Givens entire story.

Because of our early tracking and conservation measures, we never ran out. Weve been able to sustain our PPE throughout the pandemic.

Rubiela Guzman

Guzman heads up a team of 43 patient transporters at Mount Sinai Hospital. Theyre charged with moving patients quickly and safely from place to place. When the pandemic engulfed New York City, their role turned somber: wheeling patients who didnt survive COVID-19 onto refrigerated trucks when the morgue became full. Read Guzmans entire story.

The hardest part was just dealing with the overwhelming amount of patients that were passing away, Guzman says. And understanding that this was real. This is not a drill. This is not a movie,

Jessica Montanaro

Montanaro, the assistant nursing coordinator at Mount Sinai Morningside, knew emergencies like the back of her hand after years working in the hospitals medical-trauma intensive care unit. In March, however, the numbers of patients coming into her department were unlike anything shed seen before. Still, she found herself uniquely prepared for COVID-19. For the past few years, her team has been perfecting the proning technique, now widely used to help COVID patients in serious respiratory distress. Read her story.

What I was seeing, what I was experiencing, you couldnt process it. You just had to keep moving.

Christopher Wilkinson

When his manager in the bone marrow transplant unit came to Wilkinson and his colleagues to enlist them in a new program at Mount Sinai that would give gravely ill COVID-19 patients an experimental stem cell therapy, Wilkinson volunteered immediately. Though dangerous, the possibility of helping the sickest patients drew him in. The trial has shown early promise in COVID patients Wilkinson is a member of the first team in the country to use this treatment. Read his entire story.

Yes, its dangerous. Yes, we have to be careful [] I felt like it was my duty to help.

Dr. Joseph Herrera

Before COVID-19, he was a thriving sports medicine doctor. When confronted with the deadly virus, Herrera, chair of the department of rehabilitation at Mount Sinai Health System, and his department transitioned their unit into a 90-bed COVID care space. Herrera was nervous: He hadnt worked a ventilator in almost 20 years. So, he spent every waking hour not at work studying everything he could to prepare for all the unknowns. The disease was fierce, taking the lives of many patients. He worries about the safety of his wife, an anesthesiologist on the front lines in New Jersey, and his medical residents, who were redeployed to hard-hit hospitals around the city. Read his entire story.

Its just heartbreaking to hear the fear and the exhaustion and the grieving they are going through. He says: Our young doctors. Our future.

Dr. Jonathan Ramin

Ramin, a fourth-year physical rehabilitation and medicine resident at Mount Sinai, volunteered to redeploy at one of New York Citys hardest hit public hospitals. He had never experienced anything like the COVID-19 ICU. He cared for otherwise healthy people his own age and didnt know if they would live or die. However, fear often leads to hope Ramin has used his training to help rehabilitate patients recovering from the new disease. Read his full story.

Sometimes, no matter what we did for these patients no matter how young they were, no matter how healthy they were, they werent immune to this.

Dr. Michael Bell

Bell, chief of critical care medicine at Childrens National, didnt believe for a second that the novel coronavirus didnt affect children, which was rumored in the early days. Since the pandemic began, he and his team have worked around the clock, treating more than 275 kids and young adults with COVID-19. When kids started coming to the hospital with symptoms of a new mystery syndrome seemingly linked to COVID-19, his team was ready. As multisystem inflammatory syndrome (MIS-C) continued to affect children, Bell worked with teams across the country and the world to discover more. Read his story.

Its important to talk to every hospital we can find every hour of the day so we can collaborate and share information with them. We need lots of people to keep looking at it, to keep reporting it basically in real time.

Anna Stroman

When the pandemic hit Maryland, Anna Stroman, a chaplain with Doctors Community Hospital, immediately recognized a need to provide hospital employees with an outlet for stress. She created a virtual prayer line for stretched-thin front-line workers to call for a listening ear or uplifting prayer. Doctors and nurses also email in prayer requests for their seriously ill patients with COVID-19. With strict visitor restrictions in place, Stroman has found it difficult to not be able to comfort patients at their bedside. Read her full story.

Just this whole season of not being able to personally go into a patients room and sit there and talk with them is difficult. Most times, patients just want you to listen.

Diondre McBride

Though still a trainee through the Healthcare Chaplains Ministry Association, McBride is determined to pray over patients even if hes swathed in PPE and behind a barrier. Although he cannot be at their bedside, he remains committed to providing peace and light to patients, their families and hospital staff during this unprecedented time. Read his full story.

They asked me: Was I willing to put myself at risk to be chaplain during this COVID-19? I said, This is what I do. And Ive been doing it ever since.

Dr. Stephen Kates

Running out of PPE, especially N95 masks, was one of the main issues that Kates and a committee of colleagues at VCU Health in Virginia set out to address when the virus hit their hospital. Kates, chair of orthopedic surgery, used his metalworking hobby to come up with a heavy duty metal shelf that would hold a high volume of masks to allow for mass disinfection with high-intensity ultraviolet light. The system has sterilized 20,000 masks, which means the hospital hasnt run out of this necessary protective gear. Read his story.

Im happy to be able to help others with this, he says. Thats why I went into medicine, to help others.

Dr. Neal Shipley

Soon after COVID-19 flooded New York City closing many doctors offices Shipley, medical director of 52 Northwell Health-GoHealth Clinics, saw an influx of patients with fevers, upper respiratory distress and fatigue. In response, he and his staff developed a system for knowing when to send patients home, when to treat them and when to send them to the emergency room. In the first two months of the pandemic, a third of the approximately 20,000 patients coming into the urgent care centers tested positive for COVID-19. Shipleys urgent care centers are seeing high demand for both virus and antibody testing. Read his story.

When theres a second wave, if we dont have a better strategy for testing and contact tracing, I worry that all of the sacrifice will be for naught and we will be right back where we started.

Rev. Kris Pikaart

Rev. Kris Pikaart, a hospital chaplain in Gallup, New Mexico, has never worked harder than during her hours and days spent in the COVID unit. Many of the hospitals patients are residents of the Navajo Nation a community thats been hit hard by the virus, largely due to the widespread lack of running water and other resources. Pikaart, who has only taken a few days off since March, offers comfort to patients and their families, doing what she can to make this unprecedented time less awful and lonely. Read her entire story.

I have a goal that nobody here dies alone, ever, Pikaart says. I cant always make that happen because this disease is funny and its not always predictable how deaths from the disease are sometimes they happen so quickly.

Ashley Holsman

See the article here:
Fear, Courage, Grit: Meet More Than 50 'Hospital Heroes' - WTOP

Why is this nebula shaped like a butterfly? – Massive Science

Eight years ago, I was packing my home and entire life in Mexico to move to the US to pursue a PhD in Ecology and Evolutionary Biology at the University of California-Irvine. Those were easier times, although it did not seem like it at the time. I spent a few months worth of income to pay for paperwork to apply for an F-1 student visa, and to pay for other documents to enroll as a graduate student. This was after I dedicated months to emailing professors everywhere in the US, hoping that one of them would reply to my email and would invite me to apply to join their lab. It was also after spending time and money paying for standardized tests, official document translations, and application fees. It was a one-and-a-half-year process but in July 2012, I was finally moving to the USA to pursue my PhD. It was a dream come true.

It was also a dream come true for the University of California because I had a full scholarship from my home country that paid for the entirety of my international tuition and fees, which were around $35,000 per year. My scholarship allowed me to pursue my PhD in the USA, and to UC Irvine it provided basically free labor as well as prestige.

I paid taxes and did all of the typical graduate student responsibilities. I also dedicated a lot of my time to doing outreach to bring science to underserved communities around Orange County and Southern California. By the time I graduated in 2017, I was a stellar student, with three publications with UC Irvine's name on them. I co-organized summer science camps for middle school girls that brought money and a good reputation to my university and program. I mentored students of all ages. I was a good citizen of my program, of my university, and of Orange County.

Like me, most international students leave their families and everything that they are comfortable with to pursue the dream of graduate school. They bring with them the hope of being welcomed and treated fairly by their American peers. I have experienced this, but I am one of the lucky ones.

It is no secret that international students and postdocs will withstand abuse and other injustices just so they can keep their visa, which is always tied to their university. Many universities receive international students without having a system to deal with the unique challenges that international students face, such as having no credit history, which complicates finding a place to live and leaves international students vulnerable to landlord abuse. Many international students are people of color, and universities, especially predominantly white institutions, do not have resources to ensure safety of these students within the university and in the community at large.

These challenges are further complicated due to a lack of community and support. Making friends in the US, especially if you are coming from Global South countries and/or non-Westernized countries, is extremely challenging. Many times, I have seen how western Europeans, Australians, and Canadians are rapidly accepted in the local community, while many Latinx, Asians, and Middle-Easterners are not.

There are over one million international students in the US. The ICE Student Ban may no longer be a threat, but universities still need to change how they handle international students. We are people too, but many universities have historically valued us only by the amount of money we bring. We improve higher education not only by the money that we bring, but by our unique perspectives, our research productivity, and our willingness to give back to American society.

See the article here:
Why is this nebula shaped like a butterfly? - Massive Science

Anaplastic Large Cell Lymphoma Alcl Therapeutics Market is Set to Experience Revolutionary Growth by 2026 – Cole of Duty

With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and medical device industries. FMI deploys digital intelligence solutions to offercompelling insights to report buyersthat help them in overcoming market challenges, especially at the time of a crisis. Our dedicated team of professionals performs an extensive survey for gathering accurate information associated with the market.

FMI, in its upcoming business report, elaborates the historical and current scenario of the global Anaplastic Large Cell Lymphoma Alcl Therapeutics market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Crucial information and forecast statistics covered in the Anaplastic Large Cell Lymphoma Alcl Therapeutics market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

COVID-19 Impact Analysis on Anaplastic Large Cell Lymphoma Alcl Therapeutics Market

The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Anaplastic Large Cell Lymphoma Alcl Therapeutics market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Anaplastic Large Cell Lymphoma Alcl Therapeutics market.

Following governments measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMIs report includes an interesting chapter on preliminary impact of the COVID-19 on the Anaplastic Large Cell Lymphoma Alcl Therapeutics market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

To Get the Sample Copy of Report visit @

https://www.futuremarketinsights.com/reports/sample/rep-gb-1655

Why Choose Future Market Insights

Discounted prices for new customers! Offer expires soon!

Anaplastic Large Cell Lymphoma Alcl Therapeutics Market: Segmentation

Valuable information covered in the FMIs Anaplastic Large Cell Lymphoma Alcl Therapeutics market report has been segregated into key segments and sub-segments.

By Disease type

By Treatment type

Download Methodology of this Report @

https://www.futuremarketinsights.com/askus/rep-gb-1655

Anaplastic Large Cell Lymphoma Alcl Therapeutics Market: Competition Analysis

The FMIs study presents a comprehensive analysis of global, regional, and country-level players active in the Anaplastic Large Cell Lymphoma Alcl Therapeutics market.Competitive information detailed in the Anaplastic Large Cell Lymphoma Alcl Therapeutics market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Anaplastic Large Cell Lymphoma Alcl Therapeutics market report.

Key players covered in the report include:

Request for covid19 impact Analysis @

https://www.futuremarketinsights.com/covid19/rep-gb-1655

Important Questions Answered in the Anaplastic Large Cell Lymphoma Alcl Therapeutics Market Report

Key Offerings of the Report

See more here:
Anaplastic Large Cell Lymphoma Alcl Therapeutics Market is Set to Experience Revolutionary Growth by 2026 - Cole of Duty

‘I don’t have much time. I need a miracle’ why stem cell donors are urgently needed – The Times

Praxedes Garcia: Its not that I feel sorry for me. I feel sorry for my daughters

DOMENICO PUGLIESE FOR THE TIMES

Thursday July 16 2020, 12.01am, The Times

Praxedes Garcia suffers from a form of leukaemia so aggressive that her doctors have told her they have only until the end of the month to find a cure. To do so they need our help. I say I had better write this piece very quickly then.

Yes, otherwise you will feel so guilty. Oh my God! says Praxedes, who finds the humour in everything. But, she adds thoughtfully, I dont know whats the key to make people not only feel sorry for me but take some action.

Well maybe, I suggest, I should write: Praxedes needs your stem cells, which you can easily donate and which may well save her life. Perhaps that sentence should go right at the top because who reads my

Excerpt from:
'I don't have much time. I need a miracle' why stem cell donors are urgently needed - The Times

With rise in Covid cases, Surat to add 1,570 beds in 2 hospitals – The Indian Express

By: Express News Service | Surat | Published: July 16, 2020 4:57:15 am As many as 160 patients were discharged in a day, taking the total number of discharged patients to 4,908. (Representational)

In view of the rising number of Covid-19 cases, Surat city will add 1,570 more beds in two different hospitals in the city in coming days, apart from its existing 2,375 beds in various hospitals, according to government officials.

At present, Surat city has 2,375 beds at New Civil Hospital (NCH), SMIMER and 40 private hospitals for Covid treatment. As on Wednesday, there are around 1,579 patients undergoing treatment in these hospitals. As many as 770 beds are still lying vacant The stem cell hospital with 745 beds will get ready by July 20, while another 800-bed hospital will be ready by August 15, said state finance secretary Milind Torwane on Wednesday, while addressing media persons along with Surat Municipal Commissioner Banchhanidhi Pani.

Total Covid-19 cases in Surat city have gone up to 7,540 with 173 more testing positive on Wednesday, while four succumbed to the virus, taking the toll to 333. As many as 160 patients were discharged in a day, taking the total number of discharged patients to 4,908.

Torwane added, Tocilizumab injection needed for critical patients is available in sufficient quantity. The expert doctors committee formed by the government to look into the supply of such injections demand put forward by private hospitals, has till now received 250 applications from patients relatives Surat city will get 50 more such injections per day from Gandhinagar.

Apart from hospitals, seven community isolation centres, two of them with oxygen facilities, cater to patients with mild symptoms, he added.

Pointing out that people associated with diamond and textile industries are majorly affected, Surat Municipal Commissioner said, People involved in both the industries return after visiting other parts of the country and continue with their regular work, without following quarantine guidelines. In diamond industry, 1,500 positive cases have been reported while in textile sector, 1,300 workers tested positive. We have advised both the industry people to follow Standard Operating Procedure (SOP).

We are getting good response from the public through our 120 Dhanvantri raths and 104 call medical facility. When it was started, 25 patients were treated daily on an average through Dhanvatri raths but today around 25,000 people report to the raths with cold, cough and fever. Similarly, the calls received on 104 services have gone up to 100 per day from around 5 calls earlier.

The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest India News, download Indian Express App.

The Indian Express (P) Ltd

See original here:
With rise in Covid cases, Surat to add 1,570 beds in 2 hospitals - The Indian Express

It’s past time to treat international students as more than just money makers for universities – Massive Science

Eight years ago, I was packing my home and entire life in Mexico to move to the US to pursue a PhD in Ecology and Evolutionary Biology at the University of California-Irvine. Those were easier times, although it did not seem like it at the time. I spent a few months worth of income to pay for paperwork to apply for an F-1 student visa, and to pay for other documents to enroll as a graduate student. This was after I dedicated months to emailing professors everywhere in the US, hoping that one of them would reply to my email and would invite me to apply to join their lab. It was also after spending time and money paying for standardized tests, official document translations, and application fees. It was a one-and-a-half-year process but in July 2012, I was finally moving to the USA to pursue my PhD. It was a dream come true.

It was also a dream come true for the University of California because I had a full scholarship from my home country that paid for the entirety of my international tuition and fees, which were around $35,000 per year. My scholarship allowed me to pursue my PhD in the USA, and to UC Irvine it provided basically free labor as well as prestige.

I paid taxes and did all of the typical graduate student responsibilities. I also dedicated a lot of my time to doing outreach to bring science to underserved communities around Orange County and Southern California. By the time I graduated in 2017, I was a stellar student, with three publications with UC Irvine's name on them. I co-organized summer science camps for middle school girls that brought money and a good reputation to my university and program. I mentored students of all ages. I was a good citizen of my program, of my university, and of Orange County.

Like me, most international students leave their families and everything that they are comfortable with to pursue the dream of graduate school. They bring with them the hope of being welcomed and treated fairly by their American peers. I have experienced this, but I am one of the lucky ones.

It is no secret that international students and postdocs will withstand abuse and other injustices just so they can keep their visa, which is always tied to their university. Many universities receive international students without having a system to deal with the unique challenges that international students face, such as having no credit history, which complicates finding a place to live and leaves international students vulnerable to landlord abuse. Many international students are people of color, and universities, especially predominantly white institutions, do not have resources to ensure safety of these students within the university and in the community at large.

These challenges are further complicated due to a lack of community and support. Making friends in the US, especially if you are coming from Global South countries and/or non-Westernized countries, is extremely challenging. Many times, I have seen how western Europeans, Australians, and Canadians are rapidly accepted in the local community, while many Latinx, Asians, and Middle-Easterners are not.

There are over one million international students in the US. The ICE Student Ban may no longer be a threat, but universities still need to change how they handle international students. We are people too, but many universities have historically valued us only by the amount of money we bring. We improve higher education not only by the money that we bring, but by our unique perspectives, our research productivity, and our willingness to give back to American society.

Read the rest here:
It's past time to treat international students as more than just money makers for universities - Massive Science

Scientists have made an important discovery for the treatment of male infertility – The Saxon

Valery LEBOVKA, FACTS

Scientists from the U.S. made the discovery, which could subsequently solve the problem of male infertility, which may cause including disease coronavirus.

In particular, researchers have proposed of stem cells to grow a large number of blanks male sexual Taurus, which can be used for the treatment of infertility.

Description of the study published the scientific journal Proceedings of the National Academy of Sciences.

Now we are able to support the livelihoods of these cells for two to four weeks. The next task is to figure out how to get them to breed and live longer, you need to apply them in practice, said one of the authors, Professor University of California, San Diego (USA), miles Wilkinson.

According to the world health organization (who), about 10% of couples in developed and developing countries are unable to have children due to disorders in the reproductive system. As observations show doctors among men and women in the proportion of infertile are approximately equal, and most of them lose the ability to conceive a child at the age of 40-55 years.

Mechanisms of development of infertility in most cases remain unknown because of the complexity and poorly known genetic factors that control the production of ova and spermatozoa, as well as the first phases of development of the embryo. Now scientists are trying to figure out these mechanisms, trying to turn stem cells into analogs of the germ cells and various forms of embryos.

Wilkinson and his colleagues have solved one of these problems. They learned how to grow the so-called spermatogonia A-type one of types of stem cells that live in the male sex glands. They constantly multiply and serve as a kind of reservoirfrom which are constantly replenished stocks of spermatocytes stub future sperm.

As shown by experiments on animals with transplantation of these cells can be eliminated from the many forms of infertility. The problem, however, was the fact that scientists did not know how to distinguish these cells from other cell types that live in the testes, as well as to cultivate them by artificial means using reprogrammed stem cells.

Recently, as noted by Wilkinson, his team solved this problem. Scientists have developed a technique, which can be used to determine the type of each individual cellbased on unique sets of RNA, characteristic only for them. Using this technique, scientists tried to isolate pure culture of spermatogonia A-type and to understand which genes were active within them.

After analyzing three dozen samples of similar cells obtained from healthy donors, the researchers came to the conclusion that the main obstacle to their growth is a chain of genes AKT, which causes a stem cell to turn into a blank sperm.

Locking her job, Wilkinson and his colleagues were able to grow a large number of spermatogonia A-type and to maintain their existence for several weeks. Further experiments with these cells, as scientists hope will pave the way for the creation of the first effective techniques for using stem cells to treat male infertility.

Earlier, the FACTS wrote that during the communication with the readers of our publication, the medic answered questions about what types of infertility are the most common; it is difficult if full the woman is harder to get pregnant; how to prepare for pregnancy and several others.

Read more from the original source:
Scientists have made an important discovery for the treatment of male infertility - The Saxon